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The differential use of protein precursors and their products is a key strategy used during poliovirus
replication. To characterize the role of protein precursors during replication, we examined the
complementation proﬁles of mutants that inhibited 3D polymerase or 3C-RNA binding activity. We
showed that 3D entered the replication complex in the form of its precursor, P3 (or 3CD), and was
cleaved to release active 3D polymerase. Furthermore, our results showed that P3 is the preferred
precursor that binds to the 50CL. Using reciprocal complementation assays, we showed that one molecule
of P3 binds the 50CL and that a second molecule of P3 provides 3D. In addition, we showed that a second
molecule of P3 served as the VPg provider. These results support a model in which P3 binds to the 50CL
and recruits additional molecules of P3, which are cleaved to release either 3D or VPg to initiate RNA
replication.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Poliovirus (PV) is a prototypical human enterovirus, which is a
member of the small, single-strand (ss), positive sense RNA virus
family Picornaviridae. The PV genome, like that of other picorna-
viruses, is covalently linked to a viral protein, VPg, at the 50
terminus. The PV genome also contains a conserved RNA structure
in its 50 terminal sequence, the 50cloverleaf (50CL), which has been
shown to bind both cellular poly(C) binding protein (PCBP) as well
as a viral precursor protein, 3CD (Andino et al., 1990b; 1993;
Gamarnik and Andino, 1997; Parsley et al., 1997). Translation of the
viral genome utilizes an internal ribosomal entry site (IRES) to
drive synthesis of a single large open reading frame, which is
subsequently processed by the viral proteases 2A, 3C and 3CD
(reviewed in Palmenberg, 1990). Initial polyprotein processing
occurs co-translationally at the boundary between the structural
(P1) and non-structural (P23) proteins by 2A. All subsequent
cleavage events are mediated by 3C and 3CD (Wimmer et al.,
1993). Previous studies by Lawson and Semler (1992) showed that
the predominant pathway for cleavage of the P23 polyprotein was
the membrane-associated pathway starting with the cleavage at
the junction of 2A–2B (Fig. 1). This generates 2A and the precursor
protein, 2BC-P3, which is then rapidly processed to form 2BC and
P3. P3 is processed to 3CD and 3AB. Cleavage of 3AB generates 3A
and the viral protein primer, VPg (3B). 3CD is processed to yield 3C
and the active form of the polymerase, 3D. VPg is uridylylated by
the viral polymerase, 3D, to form VPgpUpU which is used as the
primer for the initiation of both () and (þ) strand synthesis.
Given the minimal coding capacity of these small RNA viruses,
the differential use of polyprotein precursors and their products is
a key strategy employed by PV to perform the many diverse
functions required during viral replication using limited sequence
space. An extension of this is the evolution of multiple activities
within a single protein or protein precursor. The PV precursor
protein, 3CD, exempliﬁes both of these concepts in that it performs
multiple functions as a precursor, and these activities are func-
tionally distinct from its processed products, 3C and 3D. As a
precursor, 3CD exhibits no polymerase activity, however its
processed product 3D, is the PV RNA-dependent RNA polymerase
(RdRp) (Flanegan and Baltimore, 1979;Flanegan and Van Dyke,
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1979;Harris et al., 1992). The 3CD precursor also has the ability to
bind to stem-loop ‘d’ of the 50CL. While this ability is partially
retained by its processed product 3C, the binding afﬁnity of 3C for
the 50CL is 10-fold lower than that of 3CD (Andino et al., 1993).
Although 3CD and 3C are proteases, their cleavage speciﬁcities and
activity levels are different. This difference is particularly apparent
in the processing of the viral capsid precursor (P1) as well as
processing at the 3C–3D junction (Parsley et al., 1999). Despite
these functional differences, there are very few structural differ-
ences between 3C and 3D individually and within the 3CD
precursor as determined by x-ray crystallography (Gruez et al.,
2008;Marcotte et al., 2007;Thompson and Peersen, 2004). A
critical difference, however, is that the N-terminal glycine residue
in 3D is buried in a pocket near the base of the ﬁngers domain in
the active 3D structure, but it is part of the 3C–3D linker in the
inactive 3CD precursor. Studies on the structure of both PV and
Coxsackievirus B3 (CVB3) 3D indicate that the buried N-terminal
glycine residue is required to activate the picornaviral polymerase
(Gruez et al., 2008;Thompson and Peersen, 2004).
Current models of PV replication complex formation invoke
genomic circularization mediated by ribonucleoprotein (RNP)
complexes formed at the 50CL and the 30NTR-poly(A) tail to
promote initiation of () strand synthesis (Barton et al., 2001;
Herold and Andino, 2001; Lyons et al., 2001;Ogram and Flanegan,
2011;Teterina et al., 2001). Viral precursor protein, 3CD, in the
presence of PCBP or 3AB, was observed to form RNP complexes
with the 50CL (Andino et al., 1990b; 1993; Harris et al., 1994;
Parsley et al., 1997; Xiang et al., 1995). In a previous study, a
revertant that contained a second site suppressor mutation in the
RNA binding domain of viral protein 3C was isolated from cells
transfected with viral RNA with an insertion mutation in stem-
loop ‘d’ (Andino et al., 1990b). This ﬁnding provided evidence for a
direct interaction between 3CD and stem-loop ‘d’ of the 50CL.
Additional studies showed that mutations in stem-loop ‘d’ of the
50CL, which disrupted 3CD binding, also inhibited PV RNA replica-
tion (Andino et al., 1993; Parsley et al., 1997; Xiang et al., 1995;
Barton et al., 2001;Vogt and Andino, 2010). Furthermore, muta-
tions in the 3C-RNA binding domain in 3CD disrupted the forma-
tion of the 50CL-RNP complex and inhibited viral RNA replication
(Andino et al., 1993;Hammerle et al., 1992;Harris et al., 1994;Blair
et al., 1998).
The results of the above studies suggest that the diverse
activities associated with 3CD, and presumably other precursor
proteins like P3, are required for PV RNA replication. Consistent
with this idea, previous studies showed that P3 was required to
complement an RNA replication-defective mutation in the 3A
region of protein 3AB (Towner et al., 1998). In addition, the results
of another study showed that P3 was required for complementa-
tion of a VPg-linkage mutant (Liu et al., 2007). Taken together,
these ﬁndings suggest that viral precursor proteins and their
processed products play distinct and essential roles in the assem-
bly of the poliovirus RNA replication complex. However, the
precise molecular mechanisms which drive the requirement for
the viral precursor proteins have not been delineated. To char-
acterize these mechanisms, we utilized the HeLa S10 translation-
replication system to examine the complementation proﬁles of
viral transcript RNAs, which contain either a 3D polymerase
mutation or a 3C-RNA binding mutation. These mutant RNAs were
assayed for their ability to assemble functional replication com-
plexes and initiate () strand synthesis. The results of the
experiments with the 3D polymerase mutant showed that 3D is
initially assembled into the replication complex in the form of its
inactive precursor, P3 or 3CD, and that 3D itself cannot assemble
into the complex. The precursor proteins are subsequently cleaved
to release active 3D for VPg uridylylation and RNA replication. In
the experiments with the 3C-RNA binding mutant, our results
showed that P3, and not 3CD, is the preferred precursor that binds
to the 50CL. Furthermore, the results of reciprocal complementa-
tion assays demonstrated that the molecule of P3 that binds the
50CL does not serve as the 3D polymerase provider. Instead, a
second molecule of P3, which does not bind RNA, functions as the
source of active 3D polymerase. Interestingly, our results also
showed that a second molecule of P3 that does not bind RNA
served as the source of VPg in the replication complex. These
ﬁndings support a model in which P3 binds to the 50CL and then
recruits additional molecules of P3, which are then cleaved to
release either active 3D or VPg for RNA replication. Taken together,
our results illustrate that the viral precursor protein, P3, performs
distinct and essential functions in the replication complex.
Results
Previous studies have identiﬁed several functions associated
with the viral protein 3CD that are required for PV RNA replication.
The initial goal of this study was to use a genetic complementation
analysis to identify speciﬁc functions of 3CD that are required to
form functional replication complexes to initiate () strand synth-
esis. Speciﬁc mutations that disrupted 3D polymerase activity, the
processing of 3CD to 3C and 3D and the RNA binding activity of 3C
(and 3CD) were constructed in a subgenomic RNA transcript, PV P23
RNA (Fig. 2B). P23 RNA encodes all of the viral replication proteins
and serves as an efﬁcient template to measure () strand synthesis.
For the complementation analysis, protein expression RNAs that
encoded P3, 3CD, 3C or 3D were constructed as described (see
Materials and methods) (Fig. 2C). () Strand synthesis was mea-
sured in preinitiation replication complexes (PIRCs) isolated from
HeLa S10 translation-RNA replication reactions containing one of
the P23 RNA mutants and one of the viral protein expression RNAs.
To conﬁrm that equivalent levels of the viral proteins were synthe-
sized in each reaction, translation of the viral transcript RNA was
measured in the presence of [35S]-methionine.
Characterization of 3D polymerase activity mutants
The ﬁrst mutant, P23-3D(G327M) RNA, contained a mutation in
the active site of the 3D, which abolishes all polymerase activity
Fig. 1. Diagram of the poliovirus P23 polyprotein processing cascade showing the
precursor and processed viral proteins. The P23 polyprotein is cleaved by the viral
protease 3C/3CD at the cleavage sites shown as ﬁlled diamonds ( ).
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(Jablonski et al., 1991). The second mutant contained changes in
the 3C–3D cleavage site, which blocked the proteolytic processing
of 3CD to 3C and 3D. Previous studies showed that 3CD does not
have any measureable RNA polymerase activity until it undergoes
proteolytic processing to release active 3D polymerase (Flanegan
and Van Dyke, 1979;Harris et al., 1992). Therefore, blocking the
proteolytic processing of 3CD maintains 3D in an inactive state.
The 3C–3D cleavage site mutant (P23-3CD(PM)) contained four
mutations at positions P1–P4 in 3C, thereby maintaining the
integrity of the amino acid sequence in 3D. The P23-3CD(PM)
mutant RNA, combined two previously described 3C–3D proces-
sing site mutations (T181K, Q182D) (Andino et al., 1990a; Harris
et al., 1992) with two additional mutations (S183G, Q184N). This
extensive mutagenesis at the 3CD processing site was required to
completely inhibit the processing of 3CD (data not shown). There-
fore, both the P23-3D(G327M) RNA and the P23-3CD(PM) RNA
were not predicted to generate active 3D and thus not support ()
strand synthesis. To conﬁrm that RNA synthesis was inhibited in
reactions containing either P23-3D(G327M) RNA or P23-3CD(PM)
RNA, we measured () strand synthesis in PIRCs isolated from
HeLa S10 reactions containing these two mutant RNAs. As
expected, 32P-labeled () strand RNA was synthesized in the
reaction containing wildtype P23 RNA (Fig. 3A, lane 1). In contrast,
detectable levels of labeled () strand RNA were not observed in
the reactions containing either P23-3D(G327M) RNA or P23-3CD
(PM) RNA (Fig. 3A, lanes 2 and 3). These results conﬁrmed that
active 3D was not produced in the reactions containing either
mutant RNA. In control experiments, we showed that both viral
protein synthesis and polyprotein processing were not affected in
reactions that contained P23-3D(G327M) RNA (Fig. 3B, compare
lanes 1 and 2). In reactions containing P23-3CD(PM) RNA, viral
protein synthesis was not affected and polyprotein processing was
normal except that 3C and 3D were not detected in the reaction, as
expected (Fig. 3B, compare lanes 1 and 3). These results conﬁrmed
that () strand synthesis was completely inhibited in reactions
that contained either the P23-3D(G327M) or the P23-3CD
(PM) RNAs.
Viral proteins 3CD or P3 were required to rescue replication of 3D
(G327M) or 3CD(PM) mutant RNAs
A complementation analysis was performed to identify the
speciﬁc viral protein, or precursor proteins, that were required to
efﬁciently rescue the replication of P23-3D(G327M) RNA. ()
Strand synthesis was measured in reactions that contained P23-
3D(G327M) RNA and a protein expression RNA that encoded either
active 3D or a 3D containing precursor proteins, 3CD or P3 (see
Materials and methods). In reactions that contained P23-3D
(G327M) RNA and wildtype 3D, only a very low level of ()
strand synthesis was observed (Fig. 4A, lane 1). In contrast, a high
level of () strand synthesis was observed in the reactions that
contained either wildtype 3CD or P3 (Fig. 4A, lanes 2 and 3). These
results demonstrated that () strand synthesis was efﬁciently
rescued on P23-3D(G327M) RNA templates in reactions that
contained either 3CD or P3.
We predicted that similar complementation results would be
observed in reactions that contained P23-3CD(PM) RNA. ()
Strand synthesis was assayed in reactions that contained P23-
3CD(PM) RNA and an expression RNA that encoded either wild-
type 3D, 3CD or P3. In the reaction that contained the P23-3CD
(PM) RNA and 3D, only very low levels of () strand synthesis
were observed (Fig. 4B, lane 1). In contrast, high levels of ()
strand syntheses were observed in reactions that contained either
3CD or P3 (Fig. 4B, lanes 2 and 3). These results showed that ()
strand synthesis on P23-3CD(PM) RNA was efﬁciently restored in
reactions that contained either wildtype 3CD or P3. As predicted,
these ﬁndings were consistent with the results observed in the
assays performed with the P23-3D(G327M) RNA. These results
indicated that 3CD or P3, but not 3D itself, was able to efﬁciently
Fig. 2. Schematic of the PV1 RNA transcripts used in this study. (A) PV1(A)80 transcript RNA contains the entire poliovirus genomic RNA sequence. This RNA encodes all of the
viral proteins and serves as a template for () strand synthesis. (B) P23 transcript RNA contains a deletion of the P1 capsid coding region, but encodes the viral replication
proteins and serves as a replicon RNA. Mutations constructed in 3C/3D/3CD are indicated by arrows and include the 3C–RNA binding mutant (RBM; K12N/R13N), the 3CD
processing mutant (PM; T181K, Q182D, S183G, Q184N), and the 3D polymerase activity mutant (G327M). (C) The viral protein expression RNA contains the speciﬁc protein
coding sequence ﬂanked by the authentic PV1 50 NTR, IRES and 30 NTR and poly(A) tail.
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complement the replication of mutant RNAs that do not encode
active 3D polymerase.
Finally, we determined if the presence of additional 3C would
enhance the ability of 3D to restore () strand synthesis in
reactions containing either P23-3D(G327M) RNA or P23-3CD
(PM) RNA. To do this, (−) strand synthesis was assayed in reactions
that contained one of the mutant RNA templates and both the 3C
and 3D expression RNAs. Low levels of () strand synthesis were
again observed in the presence of 3D (5–8%) compared to the
levels observed with 3CD (Figs. 5A and 5B, lanes 1 and 2). The
presence of additional 3C in the assay did not enhance the low
levels of () strand synthesis observed with 3D alone (Figs. 5A
and 5B, lanes 1 and 3). As expected, 3CD(PM) did not complement
the replication of P23-3D(G327M) RNA (Fig. 5A, lane 4) and 3CD
(G327M) did not complement the replication of P23-3CD(PM) RNA
(Fig. 5B, lane 4). Taken together, the results of these complemen-
tation assays showed that low levels of () strand synthesis were
observed with 3D (2–10%) compared to the levels observed with
3CD. In addition, similar levels of () strand synthesis were
observed in the presence of P3 (92–120%) compared to the levels
observed with 3CD. In summary, these results indicated that active
3D polymerase is provided by the processing of precursor proteins
P3 or 3CD in viral RNA replication complexes.
Characterization of a 3C-RNA binding mutant
We next determined the effect of a 3C-RNA binding mutant on
() strand RNA synthesis. A mutant that combined two previously
described RNA binding mutations in the N-terminal RNA binding
region of 3C was constructed in P23 RNA (i.e., P23-3C(K12N/
R13N)) and used in this study (Blair et al., 1998). We determined
the effect of this 3C-RNA binding mutant on () strand synthesis.
As expected, labeled () strand RNA was synthesized in the
reaction that contained wildtype P23 RNA (Fig. 6A, lane 1). In
contrast, () strand synthesis was completely inhibited in the
reaction that contained P23-3C(K12N/R13N) RNA (Fig. 6A, lane 2).
Viral RNA translation was also measured in these reactions and
similar levels of labeled viral proteins were observed in reactions
containing either wildtype or mutant RNAs (Fig. 6B, lanes 1 and 2).
In the reaction that contained the P23-3C(K12N/R13N) RNA, viral
protein processing was normal except for a small increase in 3C
and 3D (Fig. 6B, lane 2). These results demonstrated that ()
strand synthesis was completely inhibited by this 3C-RNA binding
mutant.
Viral protein P3 is the preferred 3C precursor that rescues replication
of a 3C-RNA binding mutant
Complementation assays provide an experimental approach to
determine the relative ability of 3C versus 3C containing precur-
sors, 3CD and P3, to rescue the replication of a 3C-RNA binding
mutant. To test this, complementation assays were performed in
Fig. 3. Characterization of mutations inhibiting 3D polymerase activity. (A) 32P-
labeled () strand RNA synthesis was assayed using PIRCs isolated from HeLa S10
reactions as described in Materials and methods. Reactions contained subgenomic
wildtype P23 RNA or P23 RNA with a mutation either in 3D (3D(G327M)) or in 3CD
coding region (3CD(PM)). Full length labeled product RNA was analyzed by
denaturing CH3HgOH gel electrophoresis and autoradiography. (B) Portions of the
HeLa S10 reactions described in (A) were labeled with [35S] methionine to assay for
protein synthesis. These reactions were analyzed by SDS-PAGE and autoradiogra-
phy. Viral proteins are indicated at left.
Fig. 4. Viral proteins 3CD or P3 were required to rescue replication of 3D(G327M)
or 3CD(PM) mutant RNAs. () Strand RNA synthesis was assayed using PIRCs
isolated from HeLa S10 reactions as described in Materials and methods.
(A) Reactions contained P23-3D(G327M) RNA as a template and a second
complementing RNA expressing the indicated protein. (B) Reactions contained
P23-3CD(PM) RNA as template and a second RNA expressing the indicated protein.
All complementing RNAs contain the ΔGUA3 mutation which inhibits () strand
synthesis. Labeled product RNA was analyzed as described in Fig.3. The amount of
the labeled product RNAs synthesized in each reaction was quantitated using
ImageJ as described in Materials and methods.
Fig. 5. The presence of additional 3C did not enhance the ability of 3D to restore (-)
strand synthesis. (−) Strand synthesis was assayed using PIRCs isolated from HeLa
S10 reactions as described in Materials and methods. Reactions contained P23-3D
(G327M) RNA (A) or P23-3CD(PM) RNA (B) and complementing RNAs expressing
the indicated protein(s). Labeled product RNA was analyzed as described in Fig. 3
and quantitated as described in Fig. 4.
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reactions that contained the RNA binding mutant P23-3C(K12N/
R13N) RNA (designated as P23-3C(RBM)) in combination with
expression RNAs that encoded 3C, 3CD or P3. () Strand synthesis
was not detected in the reaction containing 3C (Fig. 7, lane 1). In
addition, () strand synthesis was not observed even when 3 C
was expressed together with 3D (data not shown). In contrast,
measureable levels of () strand synthesis were observed in the
presence of 3CD and P3 (Fig. 7, lanes 2 and 3). Interestingly, higher
levels of () strand synthesis were observed in the presence of P3
compared to 3CD (Fig. 7, lanes 2 and 3). The level of () strand
synthesis observed with 3CD was 22% of the level observed with
P3. Taken together, these results demonstrated that P3 is the
preferred 3C precursor that is required to efﬁciently rescue
replication of P23-3C(RBM) RNA.
P3 binds to the 50CL more efﬁciently than 3CD
The ﬁnding that P3 was the preferred 3C containing precursor
that rescued the replication of P23-3C(RBM) RNA suggested that
P3 binds the 50CL more efﬁciently than 3CD. To compare the
binding of 3CD and P3 to the 50CL, we performed electrophoretic
mobility shift assays (EMSAs) using the 50CL RNA as probe in the
presence of P3 or 3CD. Since P3 and 3CD are proteolytically
cleaved to their respective cleavage products, we engineered two
previously described mutations in the active site of 3C protease
(E71Q and C147S) to prevent cleavage of P3 and 3CD (Kean et al.,
1993). EMSAs were performed with equimolar amounts of P3 and
3CD as described in Materials and methods. In mock reactions, the
50CL formed the previously characterized complex with PCBP
(Complex I) (Fig. 8, compare lanes 1 and 2) (Andino et al.,
1990a). In the reaction containing 3CD, a slower migrating com-
plex (Complex II) was observed, which was previously shown to
contain 3CD and PCBP (Andino et al., 1990a) (Fig. 8, lane 4).
Interestingly, a larger and slower migrating complex (Complex III)
was observed in reactions containing P3 (Fig. 8, lane 3). Finally, we
observed that more of the 50CL probe was shifted in the presence
of P3 compared to 3CD (Fig. 8, lanes 3 and 4). This result suggested
that P3 binds to the 50CL with higher afﬁnity than 3CD, which was
consistent with the results of the complementation assays with
the 3C-RNA binding mutant.
Fig. 7. Viral protein P3 was required to rescue replication of P23-3C(RBM). ()
Strand synthesis was assayed using PIRCs isolated from HeLa S10 reactions as
described in Materials and methods. Reactions contained P23 RNA containing a 3C-
RNA binding mutation (3C(K12N/R13N) or 3C(RBM)) and a complementing RNA
expressing the indicated protein. Labeled product RNA was analyzed as described
in Fig. 3 and quantitated as described in Fig. 4.
Fig. 8. Viral protein P3 protein binds the 50CL RNA. Electrophoretic mobility shift
assay (EMSA) using labeled 50CL RNA probe was performed as described in Materials
and methods. The position of the RNA probe is shown in lane 1. The probe was
incubated with an aliquot of a mock reaction (lane 2) or with P3 (lane 3) or 3CD (lane
4). The P3 and 3CD used in these reaction contained mutations in the active site of 3C
protease to inhibit processing of P3 and 3CD. The previously described RNP complex
formed with the 50CL RNA and PCBP is labeled as complex I (lane 2). The RNP
complex formed with the 50CL RNA and 3CD is labeled as complex II (lane 4). The
complex formed with the 50CL RNA and P3 is labeled as complex III (lane 3).
Fig. 6. Characterization of a 3C-RNA binding mutant. (A) () Strand synthesis was
assayed using PIRCs isolated from HeLa S10 reactions as described in Materials and
methods. Reactions contained either wildtype P23 RNA or a 3C-RNA binding
mutant (P23-3C(K12N/R13N)). Labeled product RNA was analyzed as described in
Fig. 3. (B) Translation of the transcript RNA was measured as described in Fig. 3B.
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Reciprocal complementation is observed between a 3D polymerase
mutant and a 3C-RNA binding mutant
The above complementation analysis showed that P3 was
required to efﬁciently complement mutations that inhibited
3C-RNA binding activity. In addition, P3 (or 3CD) was required to
efﬁciently complement mutations that inhibited 3D polymerase
activity. To determine if the RNA binding and the polymerase
activities are provided by the same or different molecules of P3,
we performed reciprocal complementation assays. The rationale
for this approach is shown in Fig. 9 for a reaction containing P3-3D
(G327M) and P3-3C(RBM). The P3-3D(G327M) can bind to the 50CL
but cannot provide active 3D polymerase. On the other hand, P3-
3C(RBM) cannot bind to the 50CL but can provide active 3D
polymerase after proteolytic processing. Therefore, if () strand
synthesis is observed, this suggests that the RNA binding and the
polymerase activities are provided by different molecules of P3. In
contrast, if () strand synthesis is not observed, this suggests that
both activities are provided by the same molecule of P3. To
distinguish between these two possibilities, we measured ()
strand synthesis in reactions containing P23-3C(RBM) RNA as the
template in the presence of P3-3D(G327M) or P3-3CD(PM) expres-
sion RNAs. As expected, () strand synthesis was observed in the
presence of wildtype P3 but not with P3-3C(RBM) (Fig. 10A and B,
lanes 1 and 3). Importantly, () strand synthesis was also
observed in the reactions containing P3-3D(G327M) (Fig. 10A, lane
2) or P3-3CD(PM) (Fig. 10B, lane 2). These results demonstrated
that both polymerase mutants were able to efﬁciently comple-
ment the replication of the 3C-RNA binding mutant RNA.
Similar reciprocal complementation experiments were performed
in reactions containing either P23-3D(G327M) or P23-3CD(PM) tem-
plate RNAs in the presence of expression RNAs that encoded wildtype
3CD, 3CD-3D(G327M) or 3CD-3C(RBM). In these experiments, 3CD
expression RNAs were used since either P3 or 3CD complemented the
replication of mutant polymerase template RNAs at about the same
levels (Fig. 4). In reactions containing P23-3D(G327M), efﬁcient
complementation was observed in the presence of 3CD or 3CD-3C
(RBM) but not in the presence of the 3CD-3D(G327M) (Fig. 10C, lanes
1–3). Likewise, in reactions containing P23-3CD(PM), efﬁcient com-
plementation was observed with 3CD or 3CD-3C(RBM), but not in the
reaction containing 3CD(PM) (Fig. 10D, lanes 1–3). These results
demonstrated that the RNA binding mutant was able to complement
both 3D polymerase mutants efﬁciently. In summary, our reciprocal
complementation analysis showed that one molecule of P3 binds RNA
and recruits a second molecule of P3 (or 3CD) which provides active
3D polymerase, but does not bind RNA.
Reciprocal complementation is observed between a 3C-RNA binding
mutant and a VPg-linkage site mutant
The results presented above demonstrated that P3 was
required to efﬁciently complement a 3C-RNA binding mutant. In
addition, the results of a previous study showed that P3 is the
preferred VPg-precursor that is required to efﬁciently complement
a VPg-linkage site mutant (Liu et al., 2007). Therefore, to deter-
mine if RNA binding activity and VPg are provided by the same or
different molecules of P3, we performed reciprocal complementa-
tion assays containing P3-3C(RBM) and P3-VPg(Y3F) (Murray and
Barton, 2003; Reuer et al., 1990). In this assay, the P3-VPg(Y3F) can
bind to the 50CL but cannot provide active VPg. In contrast, the P3-
3C(RBM) cannot bind to the 50CL but can provide active VPg after
proteolytic processing. Therefore, if () strand synthesis is
observed in this assay, this indicates that the RNA binding activity
and active VPg are provided by different molecules of P3. Alter-
natively, if () strand synthesis is not observed, this suggests that
both activities are provided by the same molecule of P3. To
distinguish between these two possibilities, we measured ()
strand synthesis in reactions containing P23-3C(RBM) RNA as the
template in the presence of P3-VPg(Y3F) expression RNA. As
Fig. 9. Model showing reciprocal complementation between a 3C-RNA binding
mutant and a 3D polymerase mutant in the same reaction. In this model, the
following multi-step process is predicted to occur during reciprocal complementa-
tion: (1) the P3-3D(G327M) provides the RNA binding activity and binds the 50CL
along with PCBP. (2) The P3-3C(RBM) is recruited to this complex and provides 3D
polymerase activity after undergoing proteolytic processing.
Fig. 10. Reciprocal complementation between a 3C-RNA binding mutant and a 3D
polymerase mutant. () Strand synthesis was assayed using PIRCs isolated from
HeLa S10 reactions as described in Materials and methods. (A) and (B) Reactions
contain P23-3C(RBM) template RNA and a second complementing RNA expressing
the indicated protein. (C) Reactions contained P23-3D(G327M) template RNA and a
second RNA expressing the indicated protein. (D) Reactions contained P23-3CD
(PM) template RNA and a second RNA expressing the indicated protein. Labeled
product RNA was analyzed as described in Fig. 3.
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expected, () strand synthesis was observed in the presence of
wildtype P3 but not with P3-3C(RBM) (Fig. 11A, lanes 1 and 3).
Interestingly, () strand synthesis was also observed in the
reaction containing P3-VPg(Y3F) (Fig. 11A, lane 2). These results
demonstrated that the P3-VPg(Y3F) mutant was able to efﬁciently
complement the replication of the P23-3C(RBM) RNA template.
This result indicated that the P3-3C(RBM), which cannot bind RNA,
served as a VPg provider in this experiment. These ﬁndings
indicated that the ﬁrst molecule of P3, which binds the 50CL, does
not serve as the VPg provider and that the second molecule of P3
serves as the VPg provider in the replication complex.
A similar reciprocal complementation experiments was per-
formed using P23-VPg(Y3F) as the template RNA in the presence of
P3-3C(RBM) RNA expression RNAs. As expected, efﬁcient ()
strand synthesis was observed in the presence of P3 but not in
reactions containing P3-VPg(Y3F) expression RNA (Fig. 11B, lanes
1 and 3). Signiﬁcantly, efﬁcient (−) strand synthesis was observed
in the reaction containing P3-3C(RBM) (Fig. 11B, lane 2). This result
showed that the RNA binding mutant was able to rescue the
replication of the VPg(Y3F) mutant. Taken together, the results of
these reciprocal complementation experiments showed that the
P3, which binds the 50CL, does not serve as the VPg provider.
Instead, a second molecule of P3, which does not bind RNA, served
as the VPg provider in the RNA replication complex.
Discussion
The work presented here illustrates the multifunctional nature
of the viral precursor protein, P3, particularly as it pertains to the
initiation of viral RNA synthesis. By performing trans-complemen-
tation assays using the HeLa S10 translation-replication system,
we have further deﬁned the role of P3, and its processed products
in the formation of a functional PV replication complex. Using this
approach, we showed that 3D polymerase is recruited to the
replication complex in the form of its precursors, P3 or 3CD, and
that RNA binding activity is not a prerequisite for this function.
Furthermore, our ﬁndings showed that P3 is the preferred pre-
cursor protein that is required to form the 50CL-RNP complex.
Results of our reciprocal complementation assays showed that the
P3 that binds to the 50CL does not function as the polymerase
provider. A second molecule of P3 (or 3CD) is recruited to the 50CL-
RNP complex and serves as the precursor of active 3D polymerase.
In addition, our results also showed that a second molecule of P3
functions as the VPg provider in the replication complex. Based on
these ﬁndings, we propose a model in which P3 binds to the 50CL
and recruits additional P3 molecules via protein–protein interac-
tions, which are then cleaved to provide active 3D and VPg for VPg
uridylylation and the initiation of RNA replication.
Active 3D polymerase is recruited into the replication complex in the
form of its inactive precursors, P3 or 3CD
Although 3CD contains the entire 3D protein, it does not have
polymerase activity (Flanegan and Baltimore, 1979; Flanegan and
Van Dyke, 1979;Harris et al., 1992). The activation of 3D is most
likely due to changes in positioning of the N-terminus of 3D that
occur subsequent to processing of the cleavage site between 3C
and 3D (Hobson et al., 2001;Marcotte et al., 2007; Rothstein et al.,
1988;Thompson and Peersen, 2004). Therefore, 3CD appears to
function as a proenzyme, which can be speciﬁcally activated by
proteolytic processing to release 3D. Our results showed that
replication of viral RNAs with mutations that inhibit polymerase
activity could not be efﬁciently rescued when 3D polymerase was
provided in trans. Efﬁcient replication of the mutant RNAs was
only observed in the presence of P3 or 3CD. Interestingly, equiva-
lent levels of replication were observed in the presence of either
P3 or 3CD (Fig. 4). This indicated that 3CD was the minimal
precursor required to rescue the replication of a polymerase
mutant. These results indicated that 3D gains the ability to enter
the replication complex when it is covalently linked to 3C. This
suggests that the 3C in 3CD (or P3) provides a function that is
required to recruit the 3D precursors into the replication complex.
These inactive precursors are then processed in the replication
Fig. 12. Model showing the role of P3 precursor protein in the multi-step process of
replication complex assembly. The cellular protein, PCBP, and the viral precursor
protein, P3, bind to the 50CL and form the 50CL-RNP complex. Pathway on the right:
A second molecule of P3 is recruited to the 50CL-RNP complex via protein–protein
interactions. This P3 serves as the 3D provider after being cleaved to release active
3D polymerase in the replication complex. Pathway on the left: A second molecule
of P3, which serves as the VPg provider, is recruited to the 50CL-RNP complex. This
P3 is cleaved to release VPg. The 3D polymerase is then used to uridylylate VPg and
to initiate and elongate VPgpUpU-primed () strand synthesis.
Fig. 11. Reciprocal complementation between a 3C–RNA binding mutant and a
VPg-linkage site mutant. () Strand synthesis was assayed using PIRCs isolated
from HeLa S10 reactions as described in Materials and methods. (A) Reactions
contain P23-3C(RBM) template RNA and a second complementing RNA expressing
the indicated protein. (B) Reactions contain P23-VPg(Y3F) template RNA and a
second RNA expressing the indicated protein. Labeled product RNA was analyzed as
described in Fig. 3.
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complex to release active 3D polymerase and initiate viral RNA
replication.
P3 is the precursor protein that is required to form the 50CL-RNP
complex
Previous studies have demonstrated the importance of 3CD
binding to stem-loop ‘d’ of the 50CL during PV RNA replication
(Andino et al., 1993; Parsley et al., 1997; Xiang et al., 1995). Three
distinct regions in the 3C protein are required for the binding of 3C
and 3CD to the 50CL (Andino et al., 1990a; Bergmann et al., 1997;
Blair et al., 1998;Matthews et al., 1994; Mosimann et al., 1997). This
includes an N-terminal region (Y6, K12, R13), a central region
(K82, F83, R84, D85, I86, R87), and a C-terminal region (T154,
G155, K156). In this study, we showed that mutations in the N-
terminal RNA binding domain (3C(K12N/R13N)) completely inhib-
ited RNA replication. In complementation assays, we observed that
3C was unable to rescue the replication of this mutant RNA when
provided in trans. In contrast, both 3CD and P3 complemented the
replication of this RNA binding mutant. Surprisingly, the level of
replication was about ﬁve times higher in the reactions containing
P3 compared to 3CD. This result suggested that P3 binds to the
50CL more efﬁciently than 3CD, which was conﬁrmed using EMSAs.
Taken together, these ﬁndings suggest that binding of 3CD to the
50CL is enhanced when it is covalently linked to 3AB in P3. In
addition, 3AB as part of P3 may facilitate the formation of a
functional membrane-associated 50CL RNP complex. In summary,
the results suggest that P3 is the preferred 3C precursor protein,
which binds to the 50CL to form the 50CL-RNP complex that is
required for viral RNA replication.
Model showing the role of the P3 precursor protein in the assembly of
a functional 50CL RNP complex
Using reciprocal complementation assays, we demonstrated
that a polymerase mutant complemented the replication of an
RNA binding mutant and vice versa. These ﬁndings support a
model in which the RNA binding activity is provided by one
molecule of P3 and the polymerase activity is provided by the
cleavage of a second molecule of P3 (or 3CD) (Fig. 12). In addition,
we showed that replication of an RNA binding mutant was rescued
by a VPg(Y3F) mutant in reciprocal complementation assays. These
results are also consistent with a model in which one molecule of
P3 binds the 50CL and a second molecule of P3 is recruited to the
complex and cleaved to provide VPg (Fig. 12).
In this model, P3 along with PCBP binds to the 50CL to form a
functional 50CL-RNP complex, which recruits a second molecule of
P3 presumably via protein–protein interactions. Based on the
results of our reciprocal complementation assays, the P3 bound
to the 50CL requires RNA binding activity, but does not serve as the
precursor for either 3D polymerase or VPg. A second molecule of
P3, which is recruited to the 50CL-RNP complex, serves as the 3D
provider in the replication complex (Fig. 12, pathway on the right).
This idea is based on our results which showed that P3 or 3CD, but
not 3D, efﬁciently complemented a polymerase mutant. This
suggests that 3D is unable to form a stable interaction with the
P3 bound to the 50CL unless 3D is covalently linked to 3C. The gain
in function provided by 3C in this case may facilitate protein-
protein interactions between the P3 molecules shown in the
model. Likewise, a second molecule of P3 is recruited to the
50CL-RNP complex to serve as the VPg provider in the replication
complex (Fig. 12, pathway on the left). In this case, P3 may also
facilitate the delivery of VPg to the replication complex by protein-
protein interactions with the P3 bound to the 50CL. Finally, the
model suggests that proteolytic cleavage of the second molecule of
P3 is required to release active 3D polymerase or VPg to the
complex. In the model, it is proposed that the bound P3 provides
the protease activity required for the cleavage of the second
molecule of P3. This allows for the activation of the polymerase
and the release of VPg at the optimal time and location in the
replication complex. The active 3D is then used to uridylylate VPg
and to initiate VPgpUpU-primed () strand synthesis (Fig. 12). In
summary, this model illustrates the multi-step process in which
viral proteins are initially assembled as precursor proteins to form
a functional 50CL-RNP complex. The precursor proteins along with
their cleaved products are then used to perform discrete and
essential functions during viral RNA replication.
Materials and methods
Poliovirus cDNA clones
A previously described cDNA clone of the Mahoney strain of
type 1 poliovirus, designated pT7-PV1(A)80, was used as the parent
clone for all poliovirus based constructs used in all studies herein
(Fig. 2A) (Barton et al., 2001). (i) pP23 is a previously described
construct with a deletion of the P1 capsid coding region (Jurgens
and Flanegan, 2003). RNA transcripts of this construct, P23 RNA,
express all essential replication proteins from the P2 and P3
regions of the viral genome. (ii) pP3ΔGUA3 was derived from a
previously described construct (pP3) which contains the coding
region for the entire P3 polyprotein precursor (Jurgens and
Flanegan, 2003). The ΔGUA3 deletion was engineered into the
pP3 by inserting a Avr II-Mlu 1 fragment derived from pT7-PV1
(A)80ΔGUA3 that has been previously described (Jurgens and
Flanegan, 2003). This 5-nt deletion in the 30 NTR (ΔGUAAA)
inhibits () strand synthesis without affecting translation
(Barton et al., 2001; Jurgens and Flanegan, 2003). Transcripts of
this construct, P3ΔGUA3 RNA, function as a helper RNA expressing
the P3 polyprotein precursor. (iii) p3CDΔGUA3 was constructed by
inserting the 3CD (nt 5438–7375) protein coding sequence in-
frame into the Msc I site of pDJB2 using the approach previously
described (Jurgens and Flanegan, 2003). The ΔGUA3 mutation was
transferred into this clone as described above. Transcripts of this
construct, 3CDΔGUA3 RNA, serve as a helper RNA expressing 3CD,
which has both RNA-binding and protease activities. (iv)
p3DΔGUA3 was constructed by inserting the 3D (nt 5987–7375)
coding sequence in-frame into the Msc I site of pDJB2, and the
ΔGUA3 mutation was transferred into this plasmid as described
above. Transcripts of this construct, 3DΔGUA3 RNA, express 3D,
which was shown in previous studies to be fully active in
polymerase elongation assays in vitro using a poliovirion RNA
template and oligo(U) primer (Eisner Smerage, 1998). (v)
p3CΔGUA3 was constructed by inserting two stop codons at the
end of the 3C coding sequence (nt 5438–5986) in p3CDΔGUA3
Transcripts of this construct, 3CΔGUA3 RNA, express proteolyti-
cally active 3C.
Mutant cDNA clones
p3CD-3D(G327M)ΔGUA3, pP3-3D(G327M)ΔGUA3 and pP23-3D
(G327M) were engineered by transferring the BstB I-Avr II frag-
ment (containing the G327M mutation) from pT7-PV1(A)80-3D
(G327M) to p3CDΔGUA3, pP3ΔGUA3 or pP23. Transcripts of these
constructs 3CD-3D(G327M)ΔGUA3 RNA, P3-3D(G327M)ΔGUA3
RNA or P23-3D(G327M) RNA express viral proteins, 3CD, P3 or
P23, respectively, which contain the G327M mutation in 3D. The
G327M mutation in the essential YGDD motif in the catalytic site
of 3D abolishes all polymerase activity (Jablonski et al., 1991)
(ii) p3CD(PM)ΔGUA3 was created by mutagenic PCR, using
p3CDΔGUA3 as a template. This mutant combines two previously
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described processing site mutations (T181K, Q182D) with two
additional mutations (S183G, Q184N) and was designed to com-
pletely abrogate 3C–3D processing (Andino et al., 1993; Blom et al.,
1996; Harris et al., 1992). Transcripts of this construct 3CD(PM)
ΔGUA3 RNA express 3CD, which retains RNA binding and protease
activity, but is not processed into 3C and active 3D. (iii) pP23-3CD
(PM) and pP3-3CD(PM)ΔGUA3 were created by transferring the Bgl
II-BstB I restriction fragment from p3CD(PM)ΔGUA3 into the
corresponding sites of pP23 and pP3ΔGUA3. (iv) p3CD-3C(K12N,
R13N)ΔGUA3, pP3-3C(K12,R13N)ΔGUA3, and pP23-3C(K12N,R13N)
were created by mutagenic PCR, using p3CDΔGUA3, pP3ΔGUA3 or
pP23 as templates, respectively. These mutations were previously
shown to inhibit the RNA binding ability of 3C (Blair et al., 1998).
(vi) pP3-3C(E71Q,C147S)ΔGUA3, p3CD-3C(E71Q,C147S) were con-
structed by mutagenic PCR using pP3ΔGUA3 and p3CDΔGUA3 as
templates, respectively. These individual mutations were pre-
viously shown to inhibit 3C protease activity (Kean et al., 1993).
We combined these mutations and conﬁrmed that 3C protease
activity was completely inhibited in reactions containing these
mutant RNAs. (vii) pP23-3B(Y3F) and pP3-3B(Y3F) were con-
structed by site directed mutagenesis using pP23ΔGUA3 and
pP3ΔGUA3 as templates. The tyrosine (Y) at position 3 in 3B
(VPg), which is the linkage site for VPg uridylylation, was changed
to phenylalanine (F). This mutation was previously shown to
inhibit VPgpUpU synthesis and viral replication (Murray and
Barton, 2003; Reuer et al., 1990). Transcripts of these constructs
are designated as P23-3B(Y3F) RNA and P3-3B(Y3F) RNA.
Preparation of RNA transcripts
Prior to in vitro transcription, the run-off transcription tem-
plate was prepared by digesting the desired plasmid DNAwithMlu
I. Digestion with this enzyme resulted in linearization of the
circular plasmid DNA via a single cut immediately following the
poliovirus 30NTR-poly(A) tail. The DNA in the restriction digest
reactions was extracted three times with phenol:chloroform, three
times with chloroform and then ethanol precipitated. TheMlu I cut
template DNA was then resuspended in Tris-EDTA buffer (10 mM
Tris–HCl (pH 8), 1 mM EDTA) at 0.5 mg/ml and stored at 20 1C.
Transcription reactions were performed as previously
described (Barton et al., 1996). Brieﬂy, these reactions contained
1X transcription buffer [40 mM Tris–HCl (pH 8), 6 mM MgCl2,
2 mM spermidine], 10 mM DTT, 0.4 U/ml RNasin (Promega), 1 mM
of each NTP (ATP, CTP, GTP and UTP), and 15 ng/ml linearized DNA.
Approximately 1 ml of puriﬁed bacterially expressed T7 polymerase
was used per 100 ml transcription reaction. Reactions were incu-
bated at 37 1C for 2 h and were stopped by the addition of
2.5 volumes of 0.5% SDS buffer [10 mM Tris–HCl (pH 7.5),
100 mM NaCl, 1 mM EDTA, 0.5% sodium dodecyl sulfate]. The
RNA transcripts were phenol: chloroform extracted three times,
chloroform extracted three times, and subsequently precipitated
by the addition of three volumes of 100% ethanol and incubated
overnight at 20 1C. The RNA transcripts were further puriﬁed by
desalting over Sephadex G-50 (GE Healthcare) gel ﬁltration resin
(0.5x13 cm column). The transcript RNAs were then stored in
ethanol at 20 1C and were precipitated immediately prior to
their use in the HeLa S10 translation-replication reaction.
HeLa S10 translation-RNA replication reactions
HeLa S10 extracts and HeLa cell translation initiation factors
were prepared as described by Barton et al. (Barton et al., 1996).
HeLa S10 translation-replication reactions were performed as
previously described with some modiﬁcations (Barton et al.,
1996). Brieﬂy, P23 RNAs (wildtype or mutant RNA as indicated)
(4 pmol total) were added to 100 μl reaction mixtures in the
presence of 2 mM guanidine HCl, and were incubated for 4 h at
34 1C. For the complementation experiments, equimolar amounts
of the template and expression RNAs (4 pmol total) were added to
100 μl reaction mixtures at the start of the incubation. Preinitia-
tion–replication complexes (PIRCs) were isolated from these reac-
tions by centrifugation and were resuspended in a replication
assay buffer containing [α-32P] CTP and 50 μg/ml puromycin as
previously described (Barton et al., 1995; 1996; 2002). The resus-
pended PIRCs were incubated at 37 1C for 1 h, and the resulting
32P-labeled () strand product RNA was puriﬁed by phenol:
chloroform extraction and ethanol precipitation. The P23 RNA
transcripts contain two 50 terminal non-viral G's, which have been
shown in previous studies to inhibit (þ)-strand but not () strand
initiation (Barton et al., 1996; Herold and Andino, 2000;Morasco et
al., 2003). Therefore, 32P-labled () strand RNA synthesis was
speciﬁcally measured in these assays.
Analysis of 32P-labeled () strand RNA
Puriﬁed labeled () strand product RNA was analyzed by
electrophoresis in CH3HgOH–1% agarose gels as previously
described (Spear et al., 2008). In these denaturing gels, RNA
structure is completely disrupted and full-length () strand RNA
runs as a single band of labeled RNA. To ensure that equivalent
amounts of RNA were loaded in each lane, the gels were stained
with ethidium bromide to verify that equivalent amounts of the
18S and 28S ribosomal RNAs were recovered in each reaction. The
labeled product RNAs were detected by autoradiography of the
dried gel. The scans of the autoradiograms were quantitated using
the image processing and analysis program, ImageJ, developed by
the National Institutes of Health.
Translation of viral RNA transcripts
To conﬁrm that equivalent levels of proteins were synthesized
in each reaction, translation reactions were performed in parallel
with RNA replication reactions as previously described (Barton
et al., 1996). Viral protein synthesis was measured by labeling of
the viral proteins using [35S]-methionine. Brieﬂy, a 10 ml aliquot of
the above described 100 ml HeLa S10 translation-replication reac-
tion was removed and incubated at 34 1C for 4 h in the presence of
11 mCi of [35S]-methionine. Following this incubation, a 5 ml aliquot
was removed and added to 45 ml of 1X Laemmli sample buffer
(20% v/v glycerol, 2% w/v SDS, 62.5 mM Tris–HCl [pH 6.8], 72 mM
β-mercaptoethanol, 0.1% w/v bromophenol blue). Samples were
heated to 95 1C for 5 min, and were analyzed by SDS-PAGE on a 9–
18% gradient gel. Labeled viral protein products were visualized by
autoradiography of the dried gel. It is important to note, that the
processing of poliovirus 3CD to 3C and 3D is known to be slow
compared to other viral precursor proteins. Therefore, relatively
low levels of released 3C and 3D are observed in these translation
reactions at 4 h. However, as shown in this manuscript these levels
of 3C and 3D were sufﬁcient to support efﬁcient () strand
synthesis in these cell-free reactions.
RNA electrophoretic mobility shift assays
To generate the 50CL RNA probe, plasmid pP23 was linearized
with Hga1, which cleaves at nucleotide position 118 at the 50 end
of the viral genome. Labeled 50CL RNA was made by T7 transcrip-
tion using the linearized DNA template in the presence of [α-32P]
CTP (400 Ci/mmol). Probes were puriﬁed using NucAway Spin
Columns (Ambion) and ethanol precipitated. The Electrophoretic
mobility shift assays (EMSAs) contained 32P-labeled 50CL RNA
(20 fmol) and were performed as previously described (Andino
et al., 1990a;Silvestri et al., 2006; Spear et al., 2008). We used P3
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and 3CD, which contained mutations (E71Q,C147S) in the active
site of 3C to inhibit 3C protease activity. HeLa S10 translation
reactions containing either P3 or 3CD expression RNAs were
incubated for 3 h at 34 1C. The mock reaction did not contain
expression RNA. The relative amounts of P3 and 3CD proteins
synthesized in the reactions was measured by labeling of the
proteins using [35S]-methionine in a parallel reaction. The labeled
proteins were analyzed by SDS-PAGE on a 12.5% gel and quanti-
tated using a PhosphorImager. The amount of labeled protein
synthesized in each reaction was determined and the relative
molar amount of each protein was calculated based on the number
of methionines. The amount of the translation reaction that was
added to the EMSAs was adjusted to ensure that equimolar
amounts of P3 and 3CD were present in each assay. The 50CL-
RNP complexes were analyzed on a 5% native polyacrylamide gel
and visualized by autoradiography.
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